Description
GLP-3 RET
Provided as a lyophilized powder that must be reconstituted with bacteriostatic water prior to research
use.
What Is Ret?
-Ret is an investigational peptide compound being studied for its potential in weight management,
metabolic health, and type 2 diabetes support.
Weight Management & Obesity
-Acts on multiple hormone receptors involved in appetite and metabolism (GLP-1, GIP, and glucagon
receptors)
-Supports fat loss by reducing hunger, increasing energy expenditure, and improving metabolic
efficiency
-Early clinical data indicate it may provide greater weight reduction compared with existing GLP-1
therapies (e.g., semaglutide)
Type 2 Diabetes & Metabolic Support
-Improves blood glucose control by enhancing insulin sensitivity and lowering blood sugar levels
-Shows promise for managing type 2 diabetes and metabolic syndrome
Important Notes
-Not FDA-approved; currently in clinical trials
-Reported side effects include nausea, diarrhea, and decreased appetite
-Further research is needed to confirm long-term safety and effectiveness
–For Research Use Only — Not Approved for Human Consumption
Reviews
There are no reviews yet.